Invivoscribe

Invivoscribe is a global leader in precision medicine and companion diagnostics (CDX) for hematological malignancies. Invivoscribe offers a full range of hematological oncology testing products and services (B-cell and T-cell clonality, NGS gene panels, MRD analysis, and integrated bioinformatics software), all developed under ISO 13485 design control and manufactured in its own cGMP facilities. The company also operates the Personalized Molecular Medicine Laboratory (LabPMM), a global network of clinical reference laboratories with branches in the United States, Germany, and Japan.